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EDITORIAL

Nephrology and Telehealth: Now? or Now!

I

n this issue of Advances in Chronic Kidney Disease,
Clarissa Diamantidis, Andrew Narva, and colleagues
provide examples of telehealth within the ﬁeld of
nephrology that are actively utilized today. They also offer
descriptions of real-world approaches to the development
and sustainability of such telehealth programs.
The concept of and the ability to provide health care
from a distance has been appealing to society and has
been practiced for centuries. This has taken the form of
warnings of impending threats and epidemics from
drums and smoke signals, written communications, and
more recently, via radio, telephones, television, and
Internet-based technologies. Historically, telemedicine
can be traced back to the mid- to late-19th century, with
one of the ﬁrst published accounts during the early 20th
century when electrocardiographic data were transmitted
over telephone wires. Telemedicine, in its modern form,
began in the 1960s, in large part driven by the military
and space technology sectors, as well as a few individuals
using readily available commercial equipment.1-3
In 1996, the Institute of Medicine deﬁned telemedicine as
the use of electronic information and communication technologies to provide and support health care when distance
separates “participants.”4 Currently, the terms telehealth
and telemedicine are used interchangeably. However, telemedicine typically describes direct clinical services,
whereas telehealth refers to a broader range of healthrelated services such as patient care, education, remote
monitoring, and provider-to-provider consultation.4
Traditional modalities of telehealth include real-time
telehealth services (a live, two-way interaction between
a patient, surrogate, or caregiver and a health care provider using audiovisual, real-time, store and forward
(permitting electronic transmission of medical information, such as digital images, documents, and prerecorded
videos through secure portals), and remote monitoring
(involves collection of a patient’s personal health and
medical data via electronic communication technologies.
Once collected, the data are transmitted to a health care
provider at a different location, allowing the provider
to continue tracking the patient’s data once the patient
has been released to his or her home or another care
facility). Mobile health is a newer concept that
describes services supported by mobile communication

devices, such as wireless patient monitoring devices,
smartphones, personal digital assistants, and tablet computers. Mobile applications (apps) and, in some instances, companion mobile devices and sensors are the
enablers of mobile health and drivers of systems. Meaningful use has speciﬁc requirements for patient engagement that can, in part, be addressed with mobile health
technologies.5,6
Telehealth offers one potential strategy to help achieve
the triple aim of better health care, improved health outcomes, and lower costs. States spend a signiﬁcant portion
of their dollars on health care, and despite a recent slowdown, new projections estimate that health care spending
in the United States will increase by an average of 5.8%
per year from 2014 to 2024.7 The cost of health care represents approximately 18% of the US Gross Domestic Product. Chronic conditions affect 140 million persons in the
United States and account for 80% of health care expenditure.8,9 Among the general Medicare population aged
65 years and older, aggregate costs for parts A, B, and D
rose 3.7% to $251 billion between 2010 and 2013,
whereas such costs rose 22.3% to $50.4 billion among
patients with CKD. Therefore, costs in the non-ESRD
CKD population exceeded those in the ESRD population
($30.9 billion USD). Costs for these patients with CKD
now represent 20.1% of all Medicare parts A, B, and D
spending. Although there was a universal rise in expenditure for all covered groups, certain patient populations
with comorbid conditions in addition to CKD experienced
higher rates of growth. Costs for patients without CKD,
diabetes mellitus, or heart failure increased by only
0.8%, the costs for those with one or more of these three
conditions increased by $9 billion, equivalent to the $9
billion increase in general Medicare spending on all
elderly patients between 2010 and 2013.10
Given greater interest in bending the cost curve, telehealth may increasingly deliver intensive services, especially to the 20% of persons who account for 80% of
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health care expenditures. As articulated by the US Senate
Committee on Finance, “Traditionally telehealth has been
viewed as a tool to improve access to services, but interest
is growing to see if telehealth has the potential to reduce
health care costs.”9 Telehealth has the potential to improve
patient access to care, decrease costs, and, possibly,
improve health care outcomes, adding to the value
component of health care.
Telehealth is suited to provide care in part or whole to
patients with CKD and can easily align within the framework of the Institute of Medicine, which espoused these
six aims for health care systems: safe, effective, patient
centered, timely, efﬁcient, and equitable. What remains
to be seen is which models of care succeed on a wider
scale. Telehealth can provide evaluation and management
services to non–dialysis-dependent CKD patients, particularly those at CKD stages 3–5. Decreased number of
clinic visits, telemonitoring and virtual rounding in dialysis units, and intensive postdischarge home telehealth
monitoring, with the goal of avoiding readmissions and
unplanned visits, all may derive from well-implemented
telehealth in CKD, otherwise referred to as telenephrology
in Europe, where unlike in the United States, widespread
adoption has already occurred.11
In a recent, randomized, controlled trial where telehealth CKD care was delivered by an interprofessional
team and compared to patients with CKD was compared
to standard care, the authors concluded that telehealth by
an interprofessional team is a feasible care delivery strategy in patients with CKD. However, there was no statistically signiﬁcant evidence of superiority of this
intervention on health outcomes compared to usual
care.12 However, the telehealth costs were not described
in the paper. Peritoneal dialysis patients have been
managed with telehealth, which provides an additional
resource for patient self-management. Patient satisfaction
scores and retention rates suggest a high level of acceptability of peritoneal dialysis in this population.13
Challenges to widespread use of telehealth remain,
including credentialing, licensure, ethical, legal, and
front-end investments issues. Traditionally, each state
and health care facility has its own processes and procedures for medical licensure and credentialing. Since telemedicine applications often cross state borders and
different facilities, the potential need to obtain licensure
and credentialing from several states and facilities may
become problematic. Policies and procedures for telemedicine reimbursement continue to evolve and remain in
transition. Also, given that policies have focused on the
provider–patient interface, determinations of how telemedicine will be reimbursed for provider-to-provider
consultation remain to be determined.11,14
Ethical dimensions of telemedicine must be confronted
and clariﬁed prior to implementation to ensure ethical
deployment. Ethical issues for patients that must be addressed include equity, privacy, conﬁdentiality, and
informed consent. Likewise, telemedicine inﬂuences the
provider–patient relationship, which may inﬂuence
ethical concerns such as the capacity for equitable treatment, cost, quality of life, and exploitation.11,15,16 In

summary, a telemedicine precondition is equitable
access to quality health care for all patients.11,17,18
Matching patients with appropriate technologies is critical. The population is aging, and those aged 65 years and
older will likely constitute 19% of the US population by
2030.19 Accompanying the aging population is the
increasing frequency of chronic health conditions and expenditures associated with chronic disease management.
Novel telehealth platforms require matching based on
age, education, interests, physical capabilities and potential limitations, familiarity, access to technology, and support to help with self-care and functional independence.
Matching patients to a proper device and gathering large
amounts of meaningful data promotes improved insight
into an individual’s disease state and better assessment
of the success of care management strategies.20
In some applications, there has been useful information
for comparative costs of telenephrology and usual care,
albeit typically short term and directed toward costs to
providers. McLean, Sheikh, and colleagues reviewed 24
cost-effectiveness studies that included formal trial data,
yet only four studies included an evaluation that encompassed the broader societal perspective. A societal
perspective considers the interests of providers, patients,
caregivers, and other stakeholders and yields the most inclusive accounting of the resource implications of interventions. In the management of CKD and associated
conditions, cost-effectiveness studies with a societal
perspective could provide greater insight into the likelihood of patient adherence, overall value, and programmatic sustainability.21,22
As telehealth plays an even greater role in global health
care delivery, it will be increasingly important to develop
a strong evidence base of successful, innovative telehealth
solutions that can lead to scalable and sustainable telehealth programs.20 Data regarding the provision of telehealth by separate groups remain limited. Among
hospitals, about 4 in 10 US hospitals have adopted telehealth, and decisions to do so appear to be shaped by a
combination of hospital-, market-, and state-level factors.
Telehealth adoption seems to be driven in part by the need
to improve access, with hospitals in more rural areas more
likely to offer telehealth than those in more urban areas.
Adoption appears shaped by perceived strategic advantages that telehealth offers hospitals. Technologically
advanced teaching hospitals in competitive markets are
more likely to have adopted telehealth compared to hospitals without advanced technology, which do not have residents and are in less competitive markets. A key
advantage of telehealth may be the ability to support the
delivery of more complex and efﬁcient care. The former
is of value to teaching hospitals that care for patients
with more complex conditions and located in areas with
limited access to specialists. The latter may be of importance to hospitals in more competitive markets that seek
technologies to help lower the cost of care delivery, such
as with teleradiology and electronic intensive care units.23
Telehealth adoption varies greatly across states. In some,
most hospitals offered telehealth services, whereas in
others, adoption was minimal. State policies related to
Adv Chronic Kidney Dis. 2017;24(1):1-3

Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by
Elsevier on June 15, 2022. For personal use only. No other uses without permission. Copyright ©2022. Elsevier Inc. All rights reserved.

Editorial

reimbursement and licensure likely inﬂuence the rate of
adoption of telehealth.23
The advent of telehealth has been compared by some to
the history of the automated teller machine (ATM). From
its humble and uncertain beginning nearly 50 years ago,
the ATM has become pervasive. When introduced in the
1970s, the ATM was an expensive, clunky, unfriendly,
and inﬂexible device solely serviced to dispense cash. Previously a ﬁnancial loss leader, the ATM is now an essential
component of ﬁnancial institutions that is fully integrated
into the global, electronic banking system.4,24
In summary, key issues that are driving the future of telehealth are many and include the following: (1) personalization of health care; (2) matching patients with
appropriate technologies; (3) optimal use of health care
data, including developing a secure interface between
patient-generated data and electronic health record; (4)
new education paradigms for patients and providers; (5)
new communities of knowledge and practice; (6) new
care and business models tailored to sustainability and
scalability of telehealth initiatives; (7) transfer of scientiﬁc
knowledge from research to implementation and practice;
and (8) innovative research methodologies within telehealth.20
Ironically, to fully harness the power of telehealth,
smartphones, and apps in health care, we must simultaneously look forward while ﬁrmly planting our footing
into our past and the time-honored tradition of caring
for our patients. We must not forget or ignore the signiﬁcance of the in-person, provider–patient visit, and the provider–patient relationship. It rests on the shoulders of
clinicians to integrate new technology with the timetested, traditional, doctor-patient interaction. Many of us
will rely on those who are on the leading edge of creating
and using technology to shepherd such technology into
health care as a supplement of and not a replacement of
this privilege.25 Many of us already have, and most of
the rest of us will. For telehealth in nephrology, it is now
or now.
The beginning is always NOW.

— Roy T. Bennett

Sandeep S. Soman, MD
Associate Editor
Jerry Yee, MD
Editor-in-Chief
Division of Nephrology and Hypertension
Henry Ford Hospital
Wayne State University
Detroit, MI
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